CTS Corporation03.14.16
Elkhart, Ind.-based, Ill.-CTS Corporation has acquired CTG Advanced Materials LLC for $73 million in cash. CTG-AM, formerly operated as H.C. Materials, is a manufacturer of single crystal piezoelectric materials, serving original equipment manufacturers (OEMs) throughout the medical marketplace. These materials enable high definition ultrasound imaging (3D and 4D), as well as intravascular ultrasound technology. Other applications for these materials include wireless pacemakers, implantable hearing aids and defense technologies.
Located in Bolingbrook, Ill., CTG-AM was founded in 1997 and since 2013 has been a portfolio company of Blue Wolf Capital Fund II, L.P. CTG-AM has vertically integrated its entire single crystal manufacturing process. With the acquisition of CTG-AM, CTS gains intellectual property and proprietary manufacturing methods that expand its offering of piezoelectric materials. This allows CTS to become the leading large-scale commercial producer of both single crystal materials and traditional piezoelectric ceramics.
“CTG-AM’s market leadership, technological expertise and winning spirit are a perfect fit for CTS,” stated Kieran O’Sullivan, CEO of CTS Corporation. “The acquisition of CTG-AM increases CTS’ involvement in the medical industry, and expands our portfolio of products and technologies around the categories of sense, connect and move.”
CTS is a designer and manufacturer of sensors, actuators and electronic components.
Located in Bolingbrook, Ill., CTG-AM was founded in 1997 and since 2013 has been a portfolio company of Blue Wolf Capital Fund II, L.P. CTG-AM has vertically integrated its entire single crystal manufacturing process. With the acquisition of CTG-AM, CTS gains intellectual property and proprietary manufacturing methods that expand its offering of piezoelectric materials. This allows CTS to become the leading large-scale commercial producer of both single crystal materials and traditional piezoelectric ceramics.
“CTG-AM’s market leadership, technological expertise and winning spirit are a perfect fit for CTS,” stated Kieran O’Sullivan, CEO of CTS Corporation. “The acquisition of CTG-AM increases CTS’ involvement in the medical industry, and expands our portfolio of products and technologies around the categories of sense, connect and move.”
CTS is a designer and manufacturer of sensors, actuators and electronic components.